| Literature DB >> 25920443 |
Michael J Flister1, Jeremy W Prokop, Jozef Lazar, Mary Shimoyama, Melinda Dwinell, Aron Geurts.
Abstract
The rat has long been a key physiological model for cardiovascular research, most of the inbred strains having been previously selected for susceptibility or resistance to various cardiovascular diseases (CVD). These CVD rat models offer a physiologically relevant background on which candidates of human CVD can be tested in a more clinically translatable experimental setting. However, a diverse toolbox for genetically modifying the rat genome to test molecular mechanisms has only recently become available. Here, we provide a high-level description of several strategies for developing genetically modified rat models of CVD.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25920443 PMCID: PMC4475456 DOI: 10.1007/s12265-015-9626-4
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132